MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-07-0001858
Wecare Formulations Private Limited
Wecare Formulations Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹75.51 Lakh
▼ 39% YoY
Net profit · FY 2024
₹33,689
Net margin 0.4%
EBITDA · FY 2024
₹1.54 Lakh
EBITDA margin 2%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹33.35 Lakh
Issued & subscribed
Open charges
₹55 Lakh
Secured borrowings
Company age
17 yrs
Est. 2009
Employees · EPFO
15
Provident fund records
About Wecare Formulations Private Limited
Data last updated:
Wecare Formulations Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 June 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2009PTC191696. Its GSTIN is 07AAACW8714C1ZH (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹33.35 Lakh. It is led by directors Rashmi Tyagi and Vikas Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2B Lgf Plot – 16 Rishab Corporate Tower Karkardooma Community Centre, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹75.51 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net profit of ₹33,689 (net margin 0.4%) and EBITDA of ₹1.54 Lakh (EBITDA margin 2%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 18% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹55 Lakh on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it.
Wecare Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-07-0001858). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999DL2009PTC191696
Registration Number 191696
Incorporation Date 29 June 2009
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-07-0001858
Key People
Rashmi Tyagi Director Vikas Kumar Director Recognitions & Rankings of Wecare Formulations
Contact details
Wecare Formulations Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address2B Lgf Plot – 16 Rishab Corporate Tower Karkardooma Community Centre, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Wecare Formulations Private Limited, buy the company report.
Comprehensive company report
Wecare Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Wecare Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Wecare Formulations Private Limited, buy the company report.
Financials of Wecare Formulations Private Limited
FY 2025 filings availableWecare Formulations Private Limited reported revenue of ₹75.51 Lakh (down 39% YoY) for FY 2024.
Revenue · FY 2024
₹75.51 Lakh ▼ 39%
Net profit · FY 2024
₹33,689 margin 0.4%
EBITDA · FY 2024
₹1.54 Lakh margin 2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 39%
3 years · compounded
▼ 25%
5 years · compounded
▼ 18%
EBITDA CAGR growth
1 year
▲ 104%
3 years · compounded
▼ 26%
5 years · compounded
▼ 37%
Revenue has declined at a compounded annual rate (CAGR) of 18% over five years, including a 39% fall in the latest year. EBITDA rose 104% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33,689 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wecare Formulations Private Limited, buy the company report.
Board of directors of Wecare Formulations Private Limited
Wecare Formulations has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rashmi Tyagi | Director | 29 Jun 2009 | 17 Years 4 Months | Current |
| Vikas Kumar | Director | 29 Jun 2009 | 17 Years 4 Months | Current |
Peer comparison
Wecare Formulations Private Limited is compared with the 5 companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Presum Pharma Private Limited | ₹75.64 Lakh (FY 2024) | 7.0% | Katihar, Bihar, India | |||
| Aarya Lifesciences Private Limited | ₹75.62 Lakh (FY 2025) | -45.0% | Ahmedabad, Gujarat, India | |||
| Wecare Formulations Private Limitedthis company | ₹75.51 Lakh (FY 2024) | ₹33,689 | 0.4% | -39.0% | 15 | Delhi, India |
| S.P. Biotech Private Limited | ₹75.48 Lakh (FY 2025) | 13.0% | Uttar Pradesh, India | |||
| Calibra Bioceuticals India Private Limited | ₹75.22 Lakh (FY 2017) | -10.0% | Hyderabad, Telangana, India | |||
| Laksh Transventure Private Limited | ₹75.21 Lakh (FY 2025) | 926.0% | Ankleshwar, Gujarat, India |
To see the full peer comparison of Wecare Formulations Private Limited, buy the company report.
Auditor
Wecare Formulations Private Limited is audited by BATRA DEEPAK & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BATRA DEEPAK & ASSOCIATES | FY 2021 | 005408C |
Shareholding
The shareholding of Wecare Formulations Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Wecare Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹55 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Mar 2015 | 10555998 | Others | ₹55 Lakh | Open |
To see the full charge records of Wecare Formulations Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Wecare Formulations Private Limited has 4 court cases on record: 3 filed by Wecare Formulations, 1 filed against it. All cases are disposed.
Total cases
4
Filed by the company
3
Filed against the company
1
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 0 |
Cases on record (2 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Interim or miscellaneous application | Filed against the company by CSL Finance Ltd. | Disposed |
| District court, East, Delhi | Criminal case | Filed by the company against an individual | Disposed |
To see the full case history of Wecare Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wecare Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Wecare Formulations Private Limited has a workforce of 15 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
15
Active EPFO establishments
1
Employee growth
-34.78%
GST
Wecare Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACW8714C1ZH | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Wecare Formulations Private Limited, buy the company report.
Recent activity
Wecare Formulations Private Limited has 3 board changes on record since 2009: 2 appointments and 1 cessation. The latest: Sanjeev Tayal ceased to be Director on 27 Oct 2010.
AGM
Wecare Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Wecare Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Others of Rs. 55.00 Lakh registered on 10 Mar 2015 with Charge ID 10555998 was modified on 27 Mar 2018.
Charges
A charge with Others amounted to Rs. 55.00 Lakh with Charge ID 10555998 was registered on 10 Mar 2015.
Ceased
Sanjeev Tayal ceased to be Director.
Appointed
Rashmi Tyagi was appointed as Director.
Appointed
Vikas Kumar was appointed as Director.
Incorporation
29 Jun 2009
Wecare Formulations Private Limited was registered on 29 Jun 2009 with Roc Delhi I & aged 17 years 4 months as per MCA records.
Frequently asked questions
Wecare Formulations is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 June 2009 (17+ years old) and is registered under CIN U74999DL2009PTC191696.
Wecare Formulations has 2 current directors:
- Rashmi Tyagi - Director
- Vikas Kumar - Director
The latest financial statements of Wecare Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Wecare Formulations is 07AAACW8714C1ZH, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Wecare Formulations is U74999DL2009PTC191696. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wecare Formulations has 4 court cases on record: 3 filed by the company and 1 filed against it.
Wecare Formulations was incorporated on 29 June 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Wecare Formulations by revenue are Presum Pharma Private Limited, Aarya Lifesciences Private Limited, S.P. Biotech Private Limited, Calibra Bioceuticals India Private Limited, Laksh Transventure Private Limited, all in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sanjeev Tayal ceased to be Director on 27 Oct 2010. Rashmi Tyagi was appointed as Director on 29 Jun 2009. Vikas Kumar was appointed as Director on 29 Jun 2009.
Yes, Wecare Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-07-0001858).
The registered office of Wecare Formulations is at 2B Lgf Plot – 16 Rishab Corporate Tower Karkardooma Community Centre, Delhi, India – 110092.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages